ATE355029T1 - Verfahren zur thrombosehemmung bei patienten deren blut extrakorporaler zirkulation ausgesetzt ist - Google Patents

Verfahren zur thrombosehemmung bei patienten deren blut extrakorporaler zirkulation ausgesetzt ist

Info

Publication number
ATE355029T1
ATE355029T1 AT99916264T AT99916264T ATE355029T1 AT E355029 T1 ATE355029 T1 AT E355029T1 AT 99916264 T AT99916264 T AT 99916264T AT 99916264 T AT99916264 T AT 99916264T AT E355029 T1 ATE355029 T1 AT E355029T1
Authority
AT
Austria
Prior art keywords
blood
extra
exposed
corporeal
patient
Prior art date
Application number
AT99916264T
Other languages
English (en)
Inventor
Eric Rose
David Stern
Ann Marie Schmidt
Talia Spanier
Original Assignee
Univ Columbia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Columbia filed Critical Univ Columbia
Application granted granted Critical
Publication of ATE355029T1 publication Critical patent/ATE355029T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96433—Serine endopeptidases (3.4.21)
    • G01N2333/96441—Serine endopeptidases (3.4.21) with definite EC number
    • G01N2333/9645—Factor IX (3.4.21.22)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Neurosurgery (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • External Artificial Organs (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
AT99916264T 1998-04-01 1999-04-01 Verfahren zur thrombosehemmung bei patienten deren blut extrakorporaler zirkulation ausgesetzt ist ATE355029T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5387298A 1998-04-01 1998-04-01

Publications (1)

Publication Number Publication Date
ATE355029T1 true ATE355029T1 (de) 2006-03-15

Family

ID=21987122

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99916264T ATE355029T1 (de) 1998-04-01 1999-04-01 Verfahren zur thrombosehemmung bei patienten deren blut extrakorporaler zirkulation ausgesetzt ist

Country Status (7)

Country Link
EP (1) EP1067879B1 (de)
JP (1) JP2002509757A (de)
AT (1) ATE355029T1 (de)
AU (1) AU3461999A (de)
CA (1) CA2326634A1 (de)
DE (1) DE69935316D1 (de)
WO (1) WO1999049803A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8128963B2 (en) 1996-09-27 2012-03-06 The Trustees Of Columbia University In The City Of New York Methods for treating ischemic disorders using carbon monoxide
US6315995B1 (en) * 1996-09-27 2001-11-13 The Trustees Of Columbia University In The City Of New York Methods for treating an ischemic disorder and improving stroke outcome
GB201420139D0 (en) 2014-11-12 2014-12-24 Ucl Business Plc Factor IX gene therapy
GB201813528D0 (en) 2018-08-20 2018-10-03 Ucl Business Plc Factor IX encoding nucleotides
US10842885B2 (en) 2018-08-20 2020-11-24 Ucl Business Ltd Factor IX encoding nucleotides

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5472850A (en) * 1991-04-10 1995-12-05 Oklahoma Medical Research Foundation Quantitative clotting assay for activated factor VII
US5583107A (en) * 1990-09-04 1996-12-10 Cor Therapeutics, Inc. Agents affecting thrombosis and hemostasis
SE470274B (sv) * 1991-11-13 1993-12-20 Bjoern Dahlbaeck Användning av en in vitro-metod för diagnos av blodkoagulationssjukdomar
US5830448A (en) * 1994-06-16 1998-11-03 Genentech, Inc. Compositions and methods for the treatment of tumors
US5839443A (en) * 1996-05-16 1998-11-24 The Trustees Of Columbia University In The City Of New York Method for inhibiting thrombosis in a patient whose blood is subjected to extracorporeal circulation
DE69737562T2 (de) * 1996-09-27 2007-12-27 The Trustees Of Columbia University In The City Of New York Behandlung einer ischämischen störung und zur verbesserung des infarktergebnis

Also Published As

Publication number Publication date
DE69935316D1 (de) 2007-04-12
WO1999049803A9 (en) 2000-02-17
JP2002509757A (ja) 2002-04-02
EP1067879A4 (de) 2002-07-17
EP1067879A1 (de) 2001-01-17
WO1999049803A1 (en) 1999-10-07
CA2326634A1 (en) 1999-10-07
EP1067879B1 (de) 2007-02-28
AU3461999A (en) 1999-10-18

Similar Documents

Publication Publication Date Title
DE69034042D1 (de) System zur verwendung in einem verfahren zur therapeutischen und diagnostischen behandlung
ATE184204T1 (de) Verfahren zur behandlung eines metallischen chirurgischen implantats.
DE69827192D1 (de) Stent und Stent-Transplantat zur Behandlung von verzweigten Blutgefässen
NO20010931L (no) Karbonylstressforbedrende middel og peritonealdialysevæske
DE69623234D1 (de) Systeme und methoden zur vorherbestimmung von parametern bei der behandlung von blut
ATE302599T1 (de) Zubereitungen und verfahren zur behandlung oder prävention von krankheiten der körperpassagewege
ATE465693T1 (de) Vorrichtung für herzklappeneingriffe
LV12558A (lv) Compositions and methods for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate
DE68918285D1 (de) Methode für behandlung von transplantaten vor transplantationen.
DE69116380D1 (de) Pharmazeutische zubereitung zur behandlung verlängerter gerinnungszeit
BR0213497A (pt) sonda vascular ou enxerto revestido ou impregnado com inibidores de proteìna tirosina cinase e método para usar o mesmo
ATE411018T1 (de) Verfahren zur behandlung oder verhinderung von vaskulärer entzündung mit sterol-absorbierungs- inhibitor(en)
NO20055382D0 (no) Bypassystem for hjerte innbefattende minimalisert utenomlegemlig blodsirkulasjonssystem og relatert fremgangsmate for anvendelse
DE60137635D1 (de) Verwendung von allopurinol zur behandlung von bluthochdruck
ATE355029T1 (de) Verfahren zur thrombosehemmung bei patienten deren blut extrakorporaler zirkulation ausgesetzt ist
EA199900724A1 (ru) Способы лечения, профилактики и защиты кровеносных сосудов от повреждений (варианты), способы лечения и профилактики различных видов гипертензии, атеросклероза (варианты)
NO972065D0 (no) Lagringsstabil vannopplösning for infusjon inneholdende en trombininhibitor
AU2420095A (en) Method of inhibiting blood coagulation during extracorporeal blood circulation and device for releasing antithrombotic drug used therein
DK1222854T3 (da) Forebyggelse og behandling af sygdomme forbundet med blodkoagulering
DE69934057D1 (de) Verfahren zur Behandlung von Alkylamino (Meth)Acrylaten
DE60023555D1 (de) Verfahren zur behandlung von gewebe
DE69227042D1 (de) Verfahren und zusammensetzungen zur verminderung von blutverlust
DE3575672D1 (de) Verfahren und loesung zur desinfektion und konservierung von kontaktlinsen.
Birch et al. Vascular reactions in an experimental burn studied with infrared thermography and microangiography
JPS62112559A (ja) 移植材料

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties